Specifically, it will be intriguing to examine how various players that are upregulated due to initial phenotypic transition (PPARγ and SREBP-1c) are stabilized due to the activation of the immune response, which is known to be a hallmark of NASH [82,83]. Here, SREBF1 is linked to metabolic dysfunction-associated steatohepatitis.